← Back
Data updated: Mar 29, 2026
ROYCE LABS
Cardiovascular
Pharma
ROYCE LABS is a pharmaceutical company focused on Cardiovascular.
-
Since
2
Drugs
-
Trials
41
Approved (2yr)
Key Drugs
No active drugs
Top Drug Revenues Pro
Loading...
Revenue Over Time Pro
Loading...
Therapeutic Areas
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Forecast
Loading...
Loading...
Upcoming Trial Milestones Pro
Loading...
Patent Cliff Pro
Loading...
Loading...
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 8